Completed OBSERVATIONAL NCT00794872

Chemoreflex Sensitivity in Chronic Kidney Disease

Hyperoxic Chemoreflex Sensitivity in Chronic Kidney Disease

Sponsor: Heinrich-Heine University, Duesseldorf

Conditions Cardiovascular Morbidity Chronic Kidney Disease

Updated 10 times since 2017 Last updated: Nov 19, 2008 Started: Jan 31, 2007 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cardiovascular Morbidity and Chronic Kidney Disease, this trial is completed. The trial is conducted by Heinrich-Heine University, Duesseldorf and has accumulated 10 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2022 — Jul 2024 [monthly]

Completed
Dec 2021 — Jun 2022 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 5 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
May 2018 — Nov 2020 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heinrich-Heine University, Duesseldorf
RWTH Aachen University
SLK Kliniken Heilbronn GmbH

Data source: RWTH Aachen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aachen, Germany